METRO NASHVILLE GENERAL HOSPITAL — History
CCN 440111 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$287M
Latest Revenue (FY2022)
+129.9%
Revenue CAGR (3yr)
48.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $54M | $55M | $287M | +425.5% | +129.9% |
| Operating Expenses | $118M | $131M | $147M | +11.8% | +11.5% |
| Operating Margin | -100.0% | -100.0% | 48.9% | +148.9% | +0.0% |
| Net Income | $-64M | $-77M | $141M | +283.4% | +0.0% |
| Licensed Beds | 114 | 114 | 114 | +0.0% | +0.0% |
| Total Patient Days | 10,489 | 11,159 | 11,115 | -0.4% | +2.9% |
| Medicare Day % | 7% | 6% | 4% | -28.0% | -21.3% |
| Medicaid Day % | 30% | 38% | 35% | -6.6% | +7.5% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +428.7% ($54M → $287M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+129.9%
This Hospital
+7.6%
State Avg
Latest Margin
48.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $404M | 123.4% |
| FY2024 (proj) | $520M | 197.8% |
| FY2025 (proj) | $637M | 272.3% |